<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2018</volume><submitter>Arwani M</submitter><pubmed_abstract>Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder, described as a clinical triad of microthrombocytopenia, eczema and recurrent infections. Different mutations in WAS gene have been identified, resulting in various phenotypes and a broad range of disease severity, ranging from classic WAS to X-linked thrombocytopenia and X-linked neutropenia. WAS in some cases can be fatal without haematopoietic stem cell transplantation early in life. In this particular case, we present a novel mutation with a unique presentation. An 18-year-old man incidentally found to have macrothrombocytopenia and neutropenia at 16 years of age later found to be hemizygous for c. 869T>C (p.Ile290Thr) mutation in WAS gene. The late presentation, absence of other manifestations of WAS and presence of macrothrombocytopenia, rather than microthrombocytopenia, which is usually a characteristic finding in WAS, misled the initial diagnosis. On review of literature, this mutation has not been reported as causing WAS.</pubmed_abstract><journal>BMJ case reports</journal><pagination>bcr-2018-225123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6047725</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.</pubmed_title><pmcid>PMC6047725</pmcid><pubmed_authors>Mewawalla P</pubmed_authors><pubmed_authors>Haddad A</pubmed_authors><pubmed_authors>Arwani M</pubmed_authors><pubmed_authors>Lee D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.</name><description>Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder, described as a clinical triad of microthrombocytopenia, eczema and recurrent infections. Different mutations in WAS gene have been identified, resulting in various phenotypes and a broad range of disease severity, ranging from classic WAS to X-linked thrombocytopenia and X-linked neutropenia. WAS in some cases can be fatal without haematopoietic stem cell transplantation early in life. In this particular case, we present a novel mutation with a unique presentation. An 18-year-old man incidentally found to have macrothrombocytopenia and neutropenia at 16 years of age later found to be hemizygous for c. 869T>C (p.Ile290Thr) mutation in WAS gene. The late presentation, absence of other manifestations of WAS and presence of macrothrombocytopenia, rather than microthrombocytopenia, which is usually a characteristic finding in WAS, misled the initial diagnosis. On review of literature, this mutation has not been reported as causing WAS.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2024-11-13T20:53:28.949Z</modification><creation>2020-11-19T13:31:25Z</creation></dates><accession>S-EPMC6047725</accession><cross_references><pubmed>29991546</pubmed><doi>10.1136/bcr-2018-225123</doi></cross_references></HashMap>